Records containing: Respiratory Viral Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23An Observational Study on the Risk of Adverse Maternal and Infant Outcomes Associated With Respiratory Viral Infections Before and During Early Pregnancy
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase I Study of Unmodified Live Intranasal Sendai Virus Vaccine in Children and Toddlers: Assessment of Safety and Immunogenicity
-
CLINICAL_TRIALS study record update · 2026-03-04Application of Myxovirus Resistance Protein A in Antiviral Treatment Guidance of Respiratory Viral Infections
-
CLINICAL_TRIALS study record update · 2025-02-05Incidence and Clinical Significance of Respiratory Viral Infections in Patients With Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2024-09-19The Development of a Human Model of Respiratory Syncytial Virus Infection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-04-09A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability,Immunogenicity, and Viral Shedding of MEDI-534, a Live, Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV), in Healthy Children 6 to <24 Months of Age